153 related articles for article (PubMed ID: 20021259)
1. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States.
Perlroth DJ; Glass RJ; Davey VJ; Cannon D; Garber AM; Owens DK
Clin Infect Dis; 2010 Jan; 50(2):165-74. PubMed ID: 20021259
[TBL] [Abstract][Full Text] [Related]
2. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
3. Mitigation of pandemic influenza: review of cost-effectiveness studies.
Lugnér AK; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
[TBL] [Abstract][Full Text] [Related]
4. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
5. Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.
Talbird SE; Brogan AJ; Winiarski AP
Am J Prev Med; 2009 Nov; 37(5):381-8. PubMed ID: 19840692
[TBL] [Abstract][Full Text] [Related]
6. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
7. Influenza and the pandemic threat.
Lee VJ; Fernandez GG; Chen MI; Lye D; Leo YS
Singapore Med J; 2006 Jun; 47(6):463-70. PubMed ID: 16752013
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.
McCaw JM; McVernon J
Math Biosci; 2007 Oct; 209(2):336-60. PubMed ID: 17416393
[TBL] [Abstract][Full Text] [Related]
9. Community planning for pandemic influenza: lessons from the VA health care system.
Lurie N; Dausey DJ; Knighton T; Moore M; Zakowski S; Deyton L
Disaster Med Public Health Prep; 2008 Dec; 2(4):251-7. PubMed ID: 18824920
[TBL] [Abstract][Full Text] [Related]
10. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply.
Medema JK; Zoellner YF; Ryan J; Palache AM
Virus Res; 2004 Jul; 103(1-2):9-15. PubMed ID: 15163482
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.
Risebrough NA; Bowles SK; Simor AE; McGeer A; Oh PI
J Am Geriatr Soc; 2005 Mar; 53(3):444-51. PubMed ID: 15743287
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
13. Healthcare epidemiology: the current status of planning for pandemic influenza and implications for health care planning in the United States.
Bartlett JG; Borio L
Clin Infect Dis; 2008 Mar; 46(6):919-25. PubMed ID: 18279045
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of preemptive school closures to mitigate pandemic influenza outbreaks of differing severity in the United States.
Dauelsberg LR; Maskery B; Joo H; Germann TC; Del Valle SY; Uzicanin A
BMC Public Health; 2024 Jan; 24(1):200. PubMed ID: 38233845
[TBL] [Abstract][Full Text] [Related]
15. Cases and deaths during influenza pandemics in the United States.
Brundage JF
Am J Prev Med; 2006 Sep; 31(3):252-6. PubMed ID: 16905037
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of influenza vaccination in working-age cancer patients.
Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
[TBL] [Abstract][Full Text] [Related]
17. [Role of antiviral drugs in containing pandemic influenza. Contribution of recent modelling exercises synthesis prepared by the InVS/Inserm "epidemiology" group - November 2005].
Lévy-Bruhl D
Med Mal Infect; 2006 Sep; 36(9):449-53. PubMed ID: 17027218
[TBL] [Abstract][Full Text] [Related]
18. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations.
Williams JP; Lednar W
Am J Manag Care; 2002 Apr; 8(5 Suppl):S143-54. PubMed ID: 11999801
[TBL] [Abstract][Full Text] [Related]
19. Optimal strategies of social distancing and vaccination against seasonal influenza.
Shim E
Math Biosci Eng; 2013; 10(5-6):1615-34. PubMed ID: 24245639
[TBL] [Abstract][Full Text] [Related]
20. Financial effects of an influenza pandemic on US hospitals.
Matheny J; Toner E; Waldhorn R
J Health Care Finance; 2007; 34(1):58-63. PubMed ID: 18972986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
